Your browser doesn't support javascript.
loading
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.
Gentile, Massimo; Shanafelt, Tait D; Mauro, Francesca R; Laurenti, Luca; Rossi, Davide; Molica, Stefano; Vincelli, Iolanda; Cutrona, Giovanna; Uccello, Giuseppina; Pepe, Sara; Vigna, Ernesto; Tripepi, Giovanni; Chaffee, Kari G; Parikh, Sameer A; Bossio, Sabrina; Recchia, Anna Grazia; Innocenti, Idanna; Pasquale, Raffaella; Neri, Antonino; Ferrarini, Manlio; Gaidano, Gianluca; Foà, Robin; Morabito, Fortunato.
Afiliação
  • Gentile M; Department of Onco-hematology, Hematology Unit, AO of Cosenza, Italy.
  • Shanafelt TD; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Mauro FR; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Laurenti L; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Rossi D; Department of Hematology, Catholic University Hospital, Agostino Gemelli, Rome, Italy.
  • Molica S; Department of Oncology and Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
  • Vincelli I; Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
  • Cutrona G; Department of Oncology and Hematology, Hematology Unit of Reggio, Calabria, Italy.
  • Uccello G; Department of Oncology and Hematology, UO Molecular Pathology, Ospedale Policlinico, San Martino, IRCCS, Genova, Italy.
  • Pepe S; Department of Onco-hematology, Hematology Unit, AO of Cosenza, Italy.
  • Vigna E; Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Tripepi G; Department of Onco-hematology, Hematology Unit, AO of Cosenza, Italy.
  • Chaffee KG; Consiglio Nazionale delle Ricerche, Istituto di Biomedicina ed Immunologia Molecolare, Reggio Calabria, Italy.
  • Parikh SA; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Bossio S; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Recchia AG; Biotechnology Research Unit, Department of Oncology and Hematology, Azienda Sanitaria Provinciale di Cosenza, Aprigliano (CS), Italy.
  • Innocenti I; Biotechnology Research Unit, Department of Oncology and Hematology, Azienda Sanitaria Provinciale di Cosenza, Aprigliano (CS), Italy.
  • Pasquale R; Department of Hematology, Catholic University Hospital, Agostino Gemelli, Rome, Italy.
  • Neri A; Department of Hematology, Catholic University Hospital, Agostino Gemelli, Rome, Italy.
  • Ferrarini M; Department of Oncology and Hemato-oncology, University of Milano and Hematology CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Gaidano G; Department of Oncology and Hematology, Direzione Scientifica, Ospedale Policlinico, San Martino, IRCCS, Genova, Italy.
  • Foà R; Division of Haematology, Università del Piemonte Orientale, Novara, Italy.
  • Morabito F; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Am J Hematol ; 93(2): E35-E37, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29098721

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália